| Application number | Title of the application | Filing Date | Status |
|---|
| 09/529691 | Inhibition of tumor cell adhesion to type iv collagen | Aug 28, 2000 | Abandoned |
Array
(
[id] => 626950
[patent_doc_number] => 07135333
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-14
[patent_title] => 'Compositions that specifically bind to colorectal cancer cells and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 09/649697
[patent_app_country] => US
[patent_app_date] => 2000-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 34581
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/135/07135333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09649697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/649697 | Compositions that specifically bind to colorectal cancer cells and methods of using the same | Aug 27, 2000 | Issued |
Array
(
[id] => 1157871
[patent_doc_number] => 06762283
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-13
[patent_title] => 'Caspase-8 interacting proteins'
[patent_app_type] => B1
[patent_app_number] => 09/644827
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 32942
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/762/06762283.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644827
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644827 | Caspase-8 interacting proteins | Aug 23, 2000 | Issued |
| 09/623036 | Use of succinate as a diagnostic tool | Aug 23, 2000 | Abandoned |
| 09/637530 | CEA/NCA-based differentiation cancer therapy | Aug 10, 2000 | Abandoned |
| 09/600871 | Specific antibodies against mammary tumor-associated mucin, method for production and use | Aug 10, 2000 | Abandoned |
Array
(
[id] => 1413879
[patent_doc_number] => 06528635
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Tumor antigen protein, gene thereof, and utilization thereof'
[patent_app_type] => B1
[patent_app_number] => 09/582324
[patent_app_country] => US
[patent_app_date] => 2000-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9251
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528635.pdf
[firstpage_image] =>[orig_patent_app_number] => 09582324
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/582324 | Tumor antigen protein, gene thereof, and utilization thereof | Aug 10, 2000 | Issued |
Array
(
[id] => 474889
[patent_doc_number] => 07226750
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-06-05
[patent_title] => 'Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/049608
[patent_app_country] => US
[patent_app_date] => 2000-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14350
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/226/07226750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10049608
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/049608 | Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof | Aug 7, 2000 | Issued |
| 09/633364 | Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions | Aug 6, 2000 | Abandoned |
Array
(
[id] => 706864
[patent_doc_number] => 07060284
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-13
[patent_title] => 'Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein'
[patent_app_type] => utility
[patent_app_number] => 09/632036
[patent_app_country] => US
[patent_app_date] => 2000-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 14132
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060284.pdf
[firstpage_image] =>[orig_patent_app_number] => 09632036
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/632036 | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein | Aug 2, 2000 | Issued |
Array
(
[id] => 1496147
[patent_doc_number] => 06403785
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Isolated DNA molecule encoding human TSC403'
[patent_app_type] => B1
[patent_app_number] => 09/601478
[patent_app_country] => US
[patent_app_date] => 2000-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13168
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403785.pdf
[firstpage_image] =>[orig_patent_app_number] => 09601478
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/601478 | Isolated DNA molecule encoding human TSC403 | Aug 2, 2000 | Issued |
Array
(
[id] => 1162219
[patent_doc_number] => 06759211
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-06
[patent_title] => 'Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/462625
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 23
[patent_no_of_words] => 35161
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09462625
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462625 | Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof | Jul 27, 2000 | Issued |
| 09/627202 | Composition and methods for the treatment of tumors | Jul 26, 2000 | Abandoned |
Array
(
[id] => 1271665
[patent_doc_number] => 06653448
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Wnt-7B-like polypeptides and nucleic acids encoding same'
[patent_app_type] => B1
[patent_app_number] => 09/625634
[patent_app_country] => US
[patent_app_date] => 2000-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 44487
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653448.pdf
[firstpage_image] =>[orig_patent_app_number] => 09625634
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/625634 | Wnt-7B-like polypeptides and nucleic acids encoding same | Jul 25, 2000 | Issued |
| 09/600840 | Monoclonal antibody anti alphanu-integrin and its use to inhibit alphanubeta6-integrin attachment to fibronectin | Jul 23, 2000 | Abandoned |
| 09/619310 | Novel fluorescent proteins | Jul 18, 2000 | Abandoned |
Array
(
[id] => 1231968
[patent_doc_number] => 06693176
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-17
[patent_title] => 'Antitumor antibodies, proteins, and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/618421
[patent_app_country] => US
[patent_app_date] => 2000-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 27
[patent_no_of_words] => 11129
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/693/06693176.pdf
[firstpage_image] =>[orig_patent_app_number] => 09618421
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/618421 | Antitumor antibodies, proteins, and uses thereof | Jul 17, 2000 | Issued |
Array
(
[id] => 951453
[patent_doc_number] => 06960658
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-01
[patent_title] => 'Maspin transcriptional regulatory sequences and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/617174
[patent_app_country] => US
[patent_app_date] => 2000-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 8386
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/960/06960658.pdf
[firstpage_image] =>[orig_patent_app_number] => 09617174
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/617174 | Maspin transcriptional regulatory sequences and uses thereof | Jul 16, 2000 | Issued |
Array
(
[id] => 714553
[patent_doc_number] => 07052703
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-30
[patent_title] => 'T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/031158
[patent_app_country] => US
[patent_app_date] => 2000-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 24587
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/052/07052703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031158 | T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof | Jul 11, 2000 | Issued |
Array
(
[id] => 1382749
[patent_doc_number] => 06555652
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Tumor antigen peptide derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/555790
[patent_app_country] => US
[patent_app_date] => 2000-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14310
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555652.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555790
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555790 | Tumor antigen peptide derivatives | Jul 11, 2000 | Issued |
